111, Inc. / Products

    { "items": [ { "from": "Product", "to": "Net revenue", "flow": 14294740000, "colorFrom": "#525f7a", "colorTo": "#525f7a" }, { "from": "Drugs", "to": "Net revenue", "flow": 13398162000, "colorFrom": "#525f7a", "colorTo": "#525f7a" }, { "from": "Nutritional Supplements", "to": "Net revenue", "flow": 550464000, "colorFrom": "#525f7a", "colorTo": "#525f7a" }, { "from": "Other Products", "to": "Net revenue", "flow": 201832000, "colorFrom": "#525f7a", "colorTo": "#525f7a" }, { "from": "Medical Supplies And Devices", "to": "Net revenue", "flow": 144282000, "colorFrom": "#525f7a", "colorTo": "#525f7a" }, { "from": "Service", "to": "Net revenue", "flow": 106509000, "colorFrom": "#525f7a", "colorTo": "#525f7a" }, { "from": "Mp Service", "to": "Net revenue", "flow": 65536000, "colorFrom": "#525f7a", "colorTo": "#525f7a" }, { "from": "Service, Other", "to": "Net revenue", "flow": 40973000, "colorFrom": "#525f7a", "colorTo": "#525f7a" }, { "from": "Net revenue", "to": "Cost of goods sold", "flow": 1645614210.5072944, "colorFrom": "#883935", "colorTo": "#883935" }, { "from": "Net revenue", "to": "Gross profit", "flow": 89287908.54003783, "colorFrom": "#1d6a54", "colorTo": "#1d6a54" }, { "from": "Gross profit", "to": "R&D expenses", "flow": 4418316.086207519, "colorFrom": "#883935", "colorTo": "#883935" }, { "from": "Gross profit", "to": "SG&A expenses", "flow": 46356901.05892132, "colorFrom": "#883935", "colorTo": "#883935" }, { "from": "Gross profit", "to": "EBITDA", "flow": 921707.2847522558, "colorFrom": "#1d6a54", "colorTo": "#1d6a54" }, { "from": "EBITDA", "to": "D&A", "flow": 18070.32972328302, "colorFrom": "#883935", "colorTo": "#883935" }, { "from": "EBITDA", "to": "EBIT", "flow": 254671.18023346865, "colorFrom": "#1d6a54", "colorTo": "#1d6a54" }, { "from": "EBIT", "to": "Tax expenses", "flow": 11565.011022901132, "colorFrom": "#883935", "colorTo": "#883935" } ], "priority": [ "Net loss", "Tax credits", "Other income", "Net income", "EBIT", "EBITDA", "Gross profit", "Net revenue", "Product", "Drugs", "Nutritional Supplements", "Other Products", "Medical Supplies And Devices", "Service", "Mp Service", "Service, Other", "Cost of goods sold", "R&D expenses", "SG&A expenses", "D&A", "Tax expenses" ] }
    Product Revenue
    Product €14.29B 824.0%
    Drugs €13.40B 772.3%
    Nutritional Supplements €550.46M 31.7%
    Other Products €201.83M 11.6%
    Medical Supplies And Devices €144.28M 8.3%
    Service €106.51M 6.1%
    Mp Service €65.54M 3.8%
    Service, Other €40.97M 2.4%

    Notifications